Mirae Asset Global Investments Co., Ltd. Biogen Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 47,553 shares of BIIB stock, worth $6.92 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
47,553
Previous 42,705
11.35%
Holding current value
$6.92 Million
Previous $8.28 Million
12.15%
% of portfolio
0.03%
Previous 0.04%
Shares
31 transactions
Others Institutions Holding BIIB
# of Institutions
995Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.43 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.37 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.12 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.07 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$765 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...